Freeze Dried Plasma (FDP) Emergency Use Authorization or FDA Licensed Product

The Department of Defense's Operational Medicine (OPMED) division is seeking to procure either an FDA-licensed Freeze Dried Plasma (FDP) product or an FDP product with current Emergency Use Authorization (EUA) from the FDA. This pre-solicitation notice is designed to identify potential industry partners who have developed FDP products at this stage of development. The procurement falls under NAICS category 325414 (Biological Product Manufacturing) and PSC category 6515 (Medical and Surgical Instruments, Equipment, and Supplies). While the notice does not explicitly detail specific evaluation criteria or technical requirements at this pre-solicitation stage, interested vendors should prepare to demonstrate FDA licensing or current EUA status for their products. The deadline for submission of interest or questions regarding this opportunity is March 25, 2026, providing potential bidders with a 16-day window from the posting date of March 9, 2026 to express interest.

This pre-solicitation notice includes no set-aside designations, meaning all qualified contractors are eligible to compete for the contract. The notice does not identify any incumbent contractors or current suppliers, nor does it specify an award value or budget range for the procurement at this time. Similarly, no information regarding quantities of FDP products needed or specific delivery timelines has been provided in this preliminary stage. Interested vendors should monitor the Federal Procurement Data System and the contracting agency's website for the full solicitation and additional procurement details, which will likely include more specific technical requirements, volume expectations, and award parameters once the formal solicitation is released.